ALLMedicine™ Diabetic Foot Infections Center
Research & Reviews 230 results
https://doi.org/10.1080/14737159.2022.2094705
Expert Review of Molecular Diagnostics; Atallah CJ, Panossian VS et. al.
Jun 28th, 2022 - : Procalcitonin (PCT) is a biomarker with established performance in the differentiation between bacterial and viral infections, predominantly in pulmonary infections, as well as the diagnosis and prognosis of bacterial sepsis. However, the role o...
https://clinicaltrials.gov/ct2/show/NCT03978715
Jun 22nd, 2022 - This will be a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investig...
https://doi.org/10.1097/SLA.0000000000005205
Annals of Surgery; Pham TT, Gariani K et. al.
May 28th, 2022 - The optimal duration of antibiotic therapy for soft-tissue infections of the diabetic foot (ST-DFI) remains unknown. We determine if antibiotic therapy after debridement for a short (10 days), compared with a long (20 days), duration for ST-DFI re...
https://clinicaltrials.gov/ct2/show/NCT05074147
May 16th, 2022 - The fight against multi-drug resistant bacteria is a global matter and a major health public issue. The excessive exposure of microorganisms to drugs increases their ability to develop survival mechanisms, causing an emerging threat and a health c...
https://clinicaltrials.gov/ct2/show/NCT05369052
May 11th, 2022 - Approximately 865 subjects (519 contezolid acefosamil/contezolid: 346 linezolid) will be enrolled with moderate or severe DFI that are confirmed or suspected to be due to a Gram-positive bacterial pathogen (MITT analysis set).
Guidelines 1 results
https://doi.org/10.1093/cid/cis346
Clinical Infectious Diseases : an Official Publication Of... Lipsky BA, Berendt AR et. al.
May 24th, 2012 - Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infecti...
Drugs 71 results see all →
Clinicaltrials.gov 25 results
https://clinicaltrials.gov/ct2/show/NCT03978715
Jun 22nd, 2022 - This will be a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investig...
https://clinicaltrials.gov/ct2/show/NCT05074147
May 16th, 2022 - The fight against multi-drug resistant bacteria is a global matter and a major health public issue. The excessive exposure of microorganisms to drugs increases their ability to develop survival mechanisms, causing an emerging threat and a health c...
https://clinicaltrials.gov/ct2/show/NCT05369052
May 11th, 2022 - Approximately 865 subjects (519 contezolid acefosamil/contezolid: 346 linezolid) will be enrolled with moderate or severe DFI that are confirmed or suspected to be due to a Gram-positive bacterial pathogen (MITT analysis set).
https://clinicaltrials.gov/ct2/show/NCT04081792
Mar 29th, 2022 - Trial 1: At enrollment (Day 1), the investigator will prescribe empiric antibiotic treatment based on instructions provided in the protocol and determine the most appropriate route of administration (oral or IV) according to the patient's conditio...
https://clinicaltrials.gov/ct2/show/NCT04714411
Nov 17th, 2021 - This is a year-long study with planned enrollment of 57 patients (in addition to 114 historical control patients) evaluating the use of omadacycline for treatment of diabetic foot infections (DFI). Omadacycline (Nuzyra®) is a FDA approved antibiot...
News 36 results
https://www.medscape.com/viewarticle/925981
Mar 2nd, 2020 - At its February meeting, the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended two antibacterial agents: cefiderocol and a generic version of tigecycline. Cefiderocol (Fetcroja, Shionogi BV) is f...
https://www.mdedge.com/familymedicine/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Dermatology News; Lucas Franki
Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.
https://www.mdedge.com/diabeteshub/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Lucas Franki
Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.
https://www.mdedge.com/dermatology/article/105627/aesthetic-dermatology/royal-jelly
Leslie S. Baumann, MD
Jan 7th, 2016 - Used for centuries by humans for its health-promoting qualities, royal jelly is a yellowish, viscous secretion from the hypopharyngeal and mandibular glands of worker bees that nourishes bee larvae of all kinds (i. e.
https://www.mdedge.com/endocrinology/article/103042/diabetes/icaac-2015-brings-three-major-systematic-reviews-diabetic-foot
Bruce Jancin
Sep 26th, 2015 - SAN DIEGO – This has been a banner year for various expert panels to weigh in on the treatment of diabetic foot infections, with three major organizations each releasing systematic reviews. And all three in-depth reports reached the same conclusio.